- Journalists Assess Risks of Tick Bites, Wildfire Smoke, Rising Health Costs
- Jefferson Health sues Independence Blue Cross over nearly $100M in disputed payments
- 240 community hospital CEOs to know | 2026
- 4 behavioral health data breaches making headlines
- 17 recent hospital, health system president exits
- 5 federal behavioral health bills for leaders to watch
- HHS appeals decision vacating provisions of 2025 ACA marketplace rule
- Imagen Dental Partners adds Seattle practice
- Texas dental practice suffers data breach
- Health systems alter approaches to workforce housing
- ACA fallout hits for-profit health systems harder than expected
- 25 new behavioral health study findings to know
- Rural hospitals build scale to stay independent: Commonwealth Fund
- Lunch, low acuity and ‘family’: How ASCs beat the CRNA cost crunch
- HCA’s $1.2B ACA hit raises red flag for nonprofit health systems
- Where AI is delivering the biggest supply chain wins
- Northwell’s Lenox Hill Hospital Brain Tumor Center Gala raises $1.6M
- Florida dental office remains closed amid patient death investigation
- Lyon College dental school names inaugural medical director for pediatric program
- A massive month for ASC policy: 5 key updates
- 130+ DSO affiliations so far in 2026: State-by-state breakdown
- AHA releases SUD treatment toolkits
- 8 DSOs making headlines
- California unveils $109M for behavioral health supportive housing
- Idaho physician to pay $1.25M for Medicare, telemedicine fraud scheme
- Connecticut enacts sweeping CON reforms: 10 things to know
- The 1st physician specialty to top $600K
- 38% of teens use a substance by age 16: 5 study notes
- Why it’s time to ‘jettison’ Stark law
- Allina Health to open 620,000-square-foot surgery center
- Tenet Healthcare shrugs off ACA headwinds with sweeping Q2 outperformance, boosts 2026 guidance
- FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
- Frequent Marijuana Use Linked To Higher Stress Hormone Levels
- What's behind Aetna's investments to build provider trust
- New university initiative offers screening, referrals for endometriosis
- Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback
- HCA Healthcare's H1 ACA volume dropoffs 'almost one for one' shifted to uninsurance
- Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
- Industry Voices—The new model for rural healthcare is already taking shape
- Amgen hands in data package in hopes of FDA hearing for Tavneos defense
- Another setback for Ipsen's Albireo portfolio as Bylvay flunks phase 3 trial
- Back Pain? Try Swimming, Study Says
- Ozempic Cuts Down Calorie Intake For At Least A Year, Even If Hunger Returns, Trial Finds
- Money Problems Might Make Your Brain Old Before Its Time, Study Suggests
- GSK’s first lung cancer approval, a new IPO path and more
- Merck stages expanded access to monthly HIV PrEP pill ahead of approval
- Black MS Patients Dying Younger Than White Ones, Study Finds
- Public Health Improvements Stall Amid Trump's DEI Crackdown
- Watch: GOP Senator Says Trump’s Tariffs Could Mean Safer Drugs — For a Price
- ‘The Child Is Terrified’: Doctors on the Front Lines of a Measles Comeback Speak Out
- To Afford Aging in Place, Older Adults Turn to ‘Golden Girls’ Housing
- Gastroenterologists flag clinical remission and its durability as unmet needs in IBD care: survey
- OpenAI makes Health in ChatGPT widely available, moving deeper into consumer health
- Many U.S. Schools Unprepared To Help Concussed Students Return To The Classroom
- Oral surgery platform buys back ownership stake from private equity firm
- Stamford Health opens EmPATH unit with follow-up care
- What will it take to truly fix anesthesia?
- 5 forces reshaping physician compensation in 2026
- Cardiologists’ pay averaged $575K in 2025, yet half feel underpaid: 10 stats to know
- New York unveils dashboard tracking mental health investments
- PDS Health-anchored retail pad in South Carolina sold for $3.7M
- 15 behavioral health services, facility closures | 2026
- Growth in a year the industry slowed: what Elevate Dental Partners is doing differently
- Philadelphia dentist whose patients were urged to get tested for HIV, hepatitis to reopen practice
- The unlicensed therapist 8 million kids are seeing
- Fierce Pharma Asia—Trump’s generic drug tariffs; Samsung Bio’s $1.8B acquisition; An unusual IPO
- New CMS data spotlight continued rise in No Surprises Act disputes
- Weekly Rundown: FDA names Dexcom as first TEMPO participant; Ardent Health tops 1M patient visits with ambient AI
- UPDATE: Peptides favored on 1st day of closely watched FDA compounding adcomm
- Nearly 1.6 Million Dozen Eggs Pulled From Shelves Over Salmonella Concerns
- Molina Healthcare plans more marketplace exits as ACA segment falters
- Organized Sports Help Enhance Motor Skills In Children With Autism
- Teal Health, UC Davis team up to expand HPV screening access
- D.C. appeals court sides with HHS in 340B drug discount program rebate challenge
- Roche defends 6B franc Vabysmo peak sales target despite another quarterly miss
- BeOne jumps aboard onshoring train with $300M to add small molecule production in US
- People Living Longer, But Spending More Years With Illness And Disability
- Exercise Underwhelms As A Hip Arthritis Treatment, Review Concludes
- Tongue Pacemaker Might Improve Sleep Apnea Patients' Health
- Poll: Costs Are Top Health Care Issue For Midterm Voters, But Fraud Tops GOP List
- Listen to the Latest ‘KFF Health News Minute’
- A Death Revives Concerns About Police Brutality Six Years After National Reckoning
- Public Health Improvements Stall Amid Trump’s DEI Crackdown
- FDA rebukes 2 Indian API plants over data controls, sanitation issues
- Australian biopharma Clinuvel to shed up to 20% of workforce in move to US
- J&J’s bispecific combo slashes myeloma progression risk by 89% in phase 3 trial
- ARS Pharma drafts NFL legend Drew Brees in allergy awareness push
- Teladoc Health unveils new virtual care model for employers, health plans that ties payment to results
- Anterior, Stellarus enter strategic partnership to speed up AI-driven prior authorizations
- Amid ACA subsidy fallout, half of Community Health Systems' Q2 volume gains were uninsured patients
- CMS appeals court decision behind 2026 MA star ratings recalculations
- Boulder Care awarded NIH grant to provide SUD care in complex settings
- Prosper Medical banks $16M to scale AI-driven concierge care platform
- CMS proposed rule lays groundwork for more OBBBA provider tax cutbacks
- Measles Cases Set 35-Year US Record With Months To Go In 2026
- Taylor Farms Faces Cyclospora Outbreak, Recalls And Political Questions
- GSK secures first lung cancer approval as FDA clears Jideytro in quick payoff from Nuvalent deal
- Cigna expands AI-powered care management programs for members
- Visana revamps well-woman visit to comprehensively address symptoms
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- What to Expect at PODD 2026
- Candid Health secures $120M series D as investment in AI-powered RCM ramps up
- GLP-1 Use Surges Among Young People With Obesity
- FDA calls out Sanofi emails for giving 'misleading impression' of Beyfortus use in RSV
- Look out Ionis, here comes Arrowhead with promising hypertriglyceridemia data
- Trump floats countdown to 200% tariffs on generic drugs imported to US
- Summit Therapeutics updates ivonescimab survival data ahead of FDA decision date
- How Does ADHD Affect Athletes' Concussion Risk?
- 1 In 4 Americans Stuck In Jobs For Health Insurance, Survey Finds
- TV Does Indeed Rot Your Brain, Study Says
- Tick-Borne Meat Allergy: Many Carry Alpha-Gal Antibodies Without Symptoms
- Agencies In New York And Beyond Pass The Buck On Opioid Cash Oversight
- American Scientists See Prosecutions as Part of Federal Campaign Against Them
- Trump’s Personnel Agency Says It Will Remove Some Identifying Info as It Sweeps Up Medical Records
- Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
- Remarks to the Small Business Capital Formation Advisory Committee
- Cannabis Drinks Sold Next To Soda Are Sending Kids To The ER, Doctors Say
- Coffee May Lower Your Heart Disease Risk, But How Much Is Safe?
- More Than Half Of US Adults Should Be Offered Statins, Study Says
- Gait Training Can Help Knee Arthritis
- The Best Surgery For Pelvic Organ Prolapse?
- Doctors 'Cringe' At Possibility Of Documenting Which Medicaid Enrollees Are Too Sick to Work
- Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages
- Leadership Vacuum: Agencies in New York and Beyond Pass the Buck on Opioid Cash Oversight
- FDA: Iceberg Lettuce Recall Stands After False Positive For Cyclospora
- Why Do So Many Women Miss The Signs Of Perimenopause?
- Virtual Therapy Sessions Improve Lives Of Kids With Lupus
- More Evidence Links Sleep Apnea To Dementia And Memory Loss
- Study Links GLP-1 Medications To Rare Vision Issue
- Gut Bacteria May Hold Key To Preventing Severe Peanut Allergies
- Trump's CDC Nominee Praises Vaccines, Without Vowing Independence From RFK Jr.
- CDC Warns Of Parasite Outbreak Tied To Taco Bell Lettuce In 5 States
- The Best Vegetables For Your Heart May Depend On Your Sex
- One Type Of ADHD Med May Affect Kids' Weight
- Poll: Many Older Americans Unaware Of 988 Suicide Help Line
- ‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- Remarks before the American-Hellenic Chamber of Commerce
- Remarks at the Society for Corporate Governance Conference
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
Michigan healthcare freedom community forum
Michigan's official vaccine stance was never in doubt, but those who like details will enjoy today's MDHHS Press Release.
I've highlighted the core argument in bold font.
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2025/09/19/standing-rec
State’s Chief Medical Executive Dr. Natasha Bagdasarian makes Standing Recommendation on COVID-19 vaccines
Determines not receiving a dose of COVID-19 vaccine to be an underlying conditionLANSING, Mich. - In response to Gov. Gretchen Whitmer’s Executive Directive to state agencies to ensure Michigan families can access COVID-19 vaccines, the state’s Chief Medical Executive Dr. Natasha Bagdasarian has issued a Standing Recommendation for the COVID-19 vaccine.
“National medical organizations and scientific experts continue to recommend routine COVID-19 vaccination for those at high risk, but also recommend vaccines be made available for all those who want them, ages six months and older,” said Bagdasarian. “COVID-19 vaccines have been proven to reduce the likelihood of emergency department or urgent care visits, as well as hospitalizations and severe outcomes. They are one of our best defenses against the virus. As the state’s chief medical executive, it is my duty to protect and promote public health, and everyone deserves the opportunity to access COVID-19 vaccine if they desire one. This Standing Recommendation will help to protect vaccine accessibility and availability in our state.”
On Wednesday, Aug. 27, the U.S. Food and Drug Administration (FDA) approved the 2025-2026 vaccine for those 65 years of age and older and those ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. However, the FDA did not define the list of underlying conditions. The Centers for Disease Control and Prevention’s list includes conditions such as obesity and physical inactivity and states it is “not exhaustive” and “should not be used to exclude people with underlying conditions from recommended measures for prevention or treatment of COVID-19.”
In her recommendation, Bagdasarian stated, “Any person over the age of six months without contraindication who has not received a dose of a Food and Drug Administration (FDA)-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is thus eligible to receive an age-appropriate dose.”
The Michigan Department of Health and Human Services (MDHHS) continues to recommend the COVID-19 vaccine in alignment with the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.
To help ensure insurance coverage and availability of COVID-19 vaccines as outlined in the Executive Directive, MDHHS is working with the Department of Insurance and Financial Services and the Michigan Department of Licensing and Regulatory Affairs.
To learn more about COVID-19 and seasonal respiratory illnesses and how to protect yourself, visit Michigan.gov/COVIDFluRSV.
# # #
In the game of governments and vaccine policy, looks like the ball is back in the Trump Administration's court. Any bets on Medicaid funding playing a major role?
LARA just issued the same presser under the subject line, "Sharing on behalf of MDHHS."
No other comment, but an early signal to every licensed health professional in Michigan that compliance is expected.
Also Friday, the CDC's recommendation changed.
My favorite part: "shared clinical decision-making." ❤️ 🥂
Close second: MedPage again referencing "pregnant women." 😊
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/117567
CDC Panel Stops Endorsing COVID Shots, Pushes for 'Choice'
— RFK Jr.'s committee breaks from flu shot model, leaves it up to individuals to decide
by Terrence Rudd, Staff Writer, MedPage Today
September 19, 2025The CDC's vaccine advisory committee is no longer recommending the COVID-19 shot for specific groups of Americans, but instead stressing shared clinical decision-making in its newest recommendations.
The Advisory Committee on Immunization Practices (ACIP) on Friday unanimously voted 12-0 to update its recommendations for pediatric and adult immunization schedules, but it deviated from recent FDA vaccine approval language by simply calling for "individual-based decision-making" in everyone ages 6 months and older.
For those 6 months to 64 years, this was paired with recommended language that added "an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors."
Until now, the vaccinations had been recommended as a routine step in the fall for nearly all Americans who wanted them -- just like a yearly flu vaccine.
Not everything earned unanimous support during the meeting. A motion to recommend that prescriptions be required to get a COVID vaccine led to a deadlocked 6-6 vote, with ACIP Chair Martin Kulldorff, PhD, formerly of Harvard Medical School in Boston, using his tie-breaking power to kill the proposal.
Panelists worried that the prescription proposal could cut pharmacists -- who administer more than 90% of all COVID shots but can't write prescriptions under Medicare Part B rules -- from the ranks of vaccination providers. The effects could slash access and clog primary care providers' offices, some members cautioned.
A third motion to strengthen discussions with patients about COVID vaccination risks and benefits also earned unanimous 12-0 approval. That recommendation calls for discussion of known risk factors for severe COVID outcomes, including age, prior infections, immunosuppression, and other comorbidities identified by the CDC, as well as "a discussion of the potential benefits and risks of vaccination and related uncertainties, especially those outlined in the vaccine information statement, as part of informed consent."
A fourth recommendation encouraged the CDC to promote more consistent, comprehensive informed consent processes, and to encourage the addition of descriptions of six risks and uncertainties outlined by ACIP member and COVID-19 working group chair Retsef Levi, PhD, of the Massachusetts Institute of Technology Sloan School of Management in Boston. That motion passed on an 11-1 vote.
Kulldorff emphasized that the vaccination schedule recommendations won't affect vaccine access in the Vaccines for Children Program -- the federally run program that covers vaccines for about half of children in the U.S.
Sean O'Leary, MD, of the American Academy of Pediatrics (AAP), said the panel's daylong debate involved clear efforts to "sow distrust" about vaccines and would have "real-time impacts on American children."
But he expressed relief that people could instead follow guidelines from his and other medical groups that still recommend the vaccines be available, like in prior years.
"It was a very, very strange meeting," O'Leary said.
A Festivus of Vaccine Uncertainties
In June, HHS Secretary Robert F. Kennedy Jr. sacked the 17 former members of ACIP and replaced them with members more aligned with his views. During the meeting, new members put plenty of focus on COVID vaccines' perceived unknown risks and uncertain benefits.
The discussion featured contentious topics including alleged DNA alterations by mRNA vaccines and case reports of myocarditis in vaccinated people, assertions that mRNA vaccines don't work as intended, the existence of a post-vaccination syndrome, and potential connections between the vaccines and conditions such as birth defects and cancer.
In a presentation to the panel, CDC COVID-19 workgroup member Henry Bernstein, DO, of the Zucker School of Medicine at Hofstra/Northwell in New York, delivered a stinging dissent to the panel's skeptical tone. The former ACIP member called for continued vaccination coverage for a wide range of populations, including pregnant women, children younger than 2 years, older adults, "and anyone who feels they want protection for themselves and their families."
"If we don't want to say vaccines are 'safe and effective,' well, they work!" Bernstein said.
ACIP, FDA, and Medical Organizations Sing Separate Tunes
Last month, the FDA approved updated COVID vaccines for the 2025-2026 respiratory virus season for all adults 65 and older, but limited their use in younger people and children to those with at least one condition that puts them at high risk for severe disease. Kennedy also announced in May that the CDC had dropped its recommendationopens in a new tab or window that healthy children and pregnant women get routine COVID shots.
Those moves prompted multiple medical organizations to issue their own vaccination recommendations, including the AAP, the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Physicians (AAFP), and the Society for Maternal-Fetal Medicine (SMFM). The AAP and AAFP said that all children ages 6 to 23 months should be vaccinated against COVID. ACOG, SMFM, and AAFP also recommended that women who are pregnant at any stage or lactating should get a COVID shot.
Health insurer industry group AHIP released a statement Tuesday that backs ACIP's older, broader COVID vaccination recommendations. "Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing for patients through the end of 2026," AHIP said.
On Friday, the Infectious Diseases Society of America (IDSA) again called for Kennedy to resign.
"His leadership has already put up barriers to many Americans' choice to receive the COVID vaccine," said IDSA President Tina Tan, MD, in a statement. "Now he is attacking routine childhood vaccines that have been given broadly and safely for decades, creating chaos and confusion, taking away parents' choices and putting children's lives at significant risk for severe vaccine-preventable diseases."
Typically, ACIP recommendations must be approved by the CDC director, and are not considered final until they are published in the Morbidity and Mortality Weekly Report.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















